Live Quote · NASDAQABOSHealthcare· Biotechnology

Acumen Pharmaceuticals, Inc.

$0.19▼ 3.52%($-0.01)
MKT CAP $13.49MNEXT EARNINGS Mar 25, 2027
50%
Bullish
TickerSpark Score
48/100
▌ Weak
100
Valuation
20
Profitability
15
Growth
76
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ABOS research report →

Analyst Price Target
$7.00+3653.4% vs. today

Range $7 – $7

Analyst RatingBuy
7 Buy1 Hold0 Sell

Price Chart

-88.04% · this period
$3.37$1.78$0.19Nov 20May 26Nov 20
52-Week Range1% of range
Low
$0.16
Current
$0.19
High
$3.60